These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7774443)

  • 1. [The effects of combined hepatectomy and immuno-chemotherapy on postoperative recurrence rate of primary liver cancer].
    Zhou W; Wu M; Chen H
    Zhonghua Wai Ke Za Zhi; 1995 Jan; 33(1):35-7. PubMed ID: 7774443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of transcatheter arterial infusion of anticancer agents with lipiodol to prevent recurrence of hepatocellular carcinoma after hepatic resection.
    Tanaka K; Shimada H; Togo S; Takahashi T; Endo I; Sekido H; Yoshida T
    Hepatogastroenterology; 1999; 46(26):1083-8. PubMed ID: 10370671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase III randomized study of interleukin-2 lymphokine-activated killer cell immunotherapy combined with chemotherapy or radiotherapy after curative or noncurative resection of primary lung carcinoma.
    Kimura H; Yamaguchi Y
    Cancer; 1997 Jul; 80(1):42-9. PubMed ID: 9210707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant hepatic arterial IL-2 and MMC, 5-FU after curative resection of colorectal liver metastases.
    Okuno K; Shigeoka H; Lee YS; Son E; Kayama H; Nakai T; Koh K; Yasutomi M
    Hepatogastroenterology; 1996; 43(9):688-91. PubMed ID: 8799416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Survival of patients with liver metastasis from colorectal cancer by different modes of therapy: a report of 363 cases].
    Xu JM; Qin XY; Zhong YS; Wei Y; Fan J; Zhou J; Qin LX; Wang JH; Yan ZP; Cheng JM; Wu ZH
    Zhonghua Zhong Liu Za Zhi; 2007 Jan; 29(1):54-7. PubMed ID: 17575696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcome of immunotherapy for patients with refractory pancreatic cancer.
    Nakamura M; Wada J; Suzuki H; Tanaka M; Katano M; Morisaki T
    Anticancer Res; 2009 Mar; 29(3):831-6. PubMed ID: 19414316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficacy of intrahepatic arterial chemotherapy to prevent recurrence of residual liver in metastatic liver cancer patients after hepatectomy].
    Hoshino M; Koyama Y; Igarashi W; Ohtake T; Ono T; Sato N; Hatakeyama Y; Abe R
    Gan To Kagaku Ryoho; 1994 Sep; 21(13):2151-4. PubMed ID: 7944426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of intraportal adoptive immunotherapy on liver metastases after resection of pancreatic cancer.
    Kobari M; Egawa S; Shibuya K; Sunamura M; Saitoh K; Matsuno S
    Br J Surg; 2000 Jan; 87(1):43-8. PubMed ID: 10606909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minimally invasive treatment combined with cytokine-induced killer cells therapy lower the short-term recurrence rates of hepatocellular carcinomas.
    Weng DS; Zhou J; Zhou QM; Zhao M; Wang QJ; Huang LX; Li YQ; Chen SP; Wu PH; Xia JC
    J Immunother; 2008 Jan; 31(1):63-71. PubMed ID: 18157013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevention of postoperative recurrence after hepatic resection for metastatic colorectal cancer by adjuvant locoregional chemotherapy].
    Endo Y; Tani T; Kawaguchi A; Eguchi Y; Sano H; Kurumi Y; Hanasawa K; Ishibashi H; Terata N; Shibata J
    Gan To Kagaku Ryoho; 1993 Aug; 20(11):1535-7. PubMed ID: 8396906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comprehensive therapy for primary liver cancer: a report of 607 cases].
    Liang AM; Mo QG; Yang NW; Zhao YN; Yuan WP
    Ai Zheng; 2004 Feb; 23(2):211-4. PubMed ID: 14960248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapeutic strategy for hepatic metastasis of primary colon cancer].
    Yukawa N; Akaike M; Sugimasa Y; Takemiya S; Motohashi H
    Gan To Kagaku Ryoho; 2001 Oct; 28(11):1565-8. PubMed ID: 11707981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical evaluation of postoperative adjuvant arterial infusion chemotherapy in resected hepatoma patients].
    Nakashima K; Aramaki M; Yoshida T; Kim YI; Kitano S; Kobayashi M; Suzuki K; Aikawa H
    Gan To Kagaku Ryoho; 1993 Aug; 20(11):1481-4. PubMed ID: 8396901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, controlled trial of postoperative adjuvant cytokine-induced killer cells immunotherapy after radical resection of hepatocellular carcinoma.
    Hui D; Qiang L; Jian W; Ti Z; Da-Lu K
    Dig Liver Dis; 2009 Jan; 41(1):36-41. PubMed ID: 18818130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Surgical treatment of primary liver cancer].
    Wu M; Chen H; Yao X
    Zhonghua Wai Ke Za Zhi; 1996 Dec; 34(12):707-10. PubMed ID: 9590765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel intrahepatic arterial chemotherapy after radical resection for advanced hepatocellular carcinoma.
    Tanaka S; Shimada M; Shirabe K; Maehara S; Harimoto N; Tsujita E; Sugimachi K; Maehara Y
    Hepatogastroenterology; 2005; 52(63):862-5. PubMed ID: 15966221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnosis and therapy for metastatic liver cancer].
    Okuno K; Koh K; Kubo R; Shindo K; Yasutomi M
    Gan To Kagaku Ryoho; 1996 Sep; 23(10):1255-61. PubMed ID: 8831736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Incidence of recurrence after hepatic resection and prophylactic hepatic arterial infusion chemotherapy for liver metastases from colon cancer].
    Umekita N; Maeshiro T; Miyamoto S; Inoue S; Kitamura M
    Gan To Kagaku Ryoho; 1999 Oct; 26(12):1702-4. PubMed ID: 10560375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The significance of portal infusion chemotherapy for prevention of recurrence in residual liver after hepatectomy for metastases from colorectal cancer].
    Takano S; Moriguchi M; Seki N; Higaki T; Watanabe Y; Takahashi T; Ito Y; Oishi H; Nakata Y; Kono S
    Gan To Kagaku Ryoho; 1994 Sep; 21(13):2176-8. PubMed ID: 7944433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of intraarterial infusion chemotherapy for liver metastasis from gastric cancer FEM: combination therapy of 5-FU, epirubicin and MMC].
    Takada J; Katsuki Y; Hamada H; Tsuji Y
    Gan To Kagaku Ryoho; 2003 Oct; 30(11):1627-30. PubMed ID: 14619480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.